Virginia Babies Born Addicted to Opioids Have Quadrupled in the Last 4 Years
RICHMOND, Aug 31, 2017 — The Virginia Hospital & Healthcare Association (VHHA) Shared Services Corporation has partnered with Cordant Health Solutions™ (Cordant) to combat the epidemic of infants being born with drug-withdrawal symptoms, a condition known as neonatal abstinence syndrome (NAS). Data show that the number of NAS cases has quadrupled in Virginia from 2012 to 2016, according to the Virginia Hospital and Healthcare Association.
Cordant, a nationwide drug testing and specialized controlled substance pharmacy company, offers several advanced testing and patient and physician-education protocols to address cases involving infants experiencing withdrawal after being born following consistent exposure to opioids in utero.
“A baby born with NAS has longer hospital stays, increased medical costs and may experience a series of lifelong health challenges,” said David Jenkins, vice president and chief operating officer of VHHA Shared Services.
Cordant’s services include testing protocols, advanced testing methods and patient and provider education. Testing begins early in pregnancy, enabling physicians to intervene as necessary. Testing and reviews of prescription and pharmacy history, where available, have been shown to improve outcomes for mothers and babies.